SRL172 Summary

25 relevant articles (6 outcomes, 17 trials/studies) found for this Bio-Agent

Key Diseases for which SRL172 is Relevant

1. Neoplasms (Cancer) : 2 outcomes 2 studies in 3 results
   
2. Small Cell Lung Carcinoma (Small Cell Lung Cancer) : 1 outcome 4 studies in 5 results
   
3. Melanoma (Melanoma, Malignant) : 1 outcome 2 studies in 2 results
   
4. Adenocarcinoma : 1 outcome 1 study in 2 results
   
5. Atopic Dermatitis (Atopic Eczema) : 1 outcome 1 study in 1 result
   

Drugs Related to SRL172

1. Interleukin-2 (IL2)
2. trastuzumab (Herceptin)
3. Mitomycin (Mitomycin-C)
4. Cytokines
5. Vinblastine (Vinblastine Sulfate)
6. Cisplatin (Platino)
7. Hepatitis B Vaccines (Hepatitis B Vaccine)
8. Staphylococcal Protein A (A, Protein)
9. Hormones
10. Immunologic Adjuvants (Immunologic Adjuvant)

Therapies Related to SRL172

1. Drug Therapy (Chemotherapy)
2. Immunotherapy
3. Nephrectomy
4. Intradermal Injections
5. Injections